Hemangiomatosis’in Metilprednizolon ile Tedavisi

Journal Title: Turkish Journal of Hematology - Year 2012, Vol 29, Issue 4

Abstract

Authors and Affiliations

Şinasi Özsoylu

Keywords

Related Articles

TET2, ASXL1, IDH1, and IDH2 Single Nucleotide Polymorphisms in Turkish Patients with Chronic Myeloproliferative Neoplasms

We aimed to determine the genotype distribution, allele frequency, and prognostic impact of IDH1/2, TET2, and ASXL1 single nucleotide polymorphisms (SNPs) in myeloproliferative neoplasms (MPNs). TET2 (rs763480), ASXL1 (r...

Tumor Necrosis Factor Alpha (TNF-α) –308G/A Polymorphism and the Risk of Multiple Myeloma: A Meta-analysis of Pooled Data from 12 Case-control Studies

Objective: Tumor necrosis factor alpha (TNF-α) is an important cytokine involved in inflammation, immune response, and other biological processes. The association between polymorphism -308G/A in its promoter and the risk...

Comparative Analyses of Immunosuppressive Characteristics of Bone-Marrow, Wharton’s Jelly, and Adipose Tissue-Derived Human Mesenchymal Stem Cells

Objective: Mesenchymal stem cells (MSCs), which possess immunosuppressive characteristics on induced T-cells, were shown to be applicable in prevention and treatment of graft-versus-host disease. However, knowledge of ef...

Download PDF file
  • EP ID EP137498
  • DOI 10.5505/tjh.2012.55706
  • Views 70
  • Downloads 0

How To Cite

Şinasi Özsoylu (2012). Hemangiomatosis’in Metilprednizolon ile Tedavisi. Turkish Journal of Hematology, 29(4), 436-437. https://europub.co.uk/articles/-A-137498